The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Mendlein John since year 2005.
The trader's CIK number is 1238362.
At the time of this reporting, Mendlein John is the CEO and Director of Atyr Pharma Inc .
(stock ticker symbol LIFE).
See this page for all insider trading activities at Atyr Pharma Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-08-31||LIFE||Atyr Pharma Inc||Buy||37,736||2.65||100,000|
|2017-04-24||LIFE||Atyr Pharma Inc||Buy||124||3.00||372|
|2017-04-20||LIFE||Atyr Pharma Inc||Buy||1,552||3.00||4,656|
|2017-04-18||LIFE||Atyr Pharma Inc||Buy||1,000||3.00||3,000|
|2016-12-19||LIFE||Atyr Pharma Inc||Buy||69,000||2.20||151,662|
|2016-04-05||LIFE||Atyr Pharma Inc||Buy||2,500||3.52||8,800|
|2016-04-05||LIFE||Atyr Pharma Inc||Buy||2,500||3.55||8,875|
|2013-10-04||FATE||Fate Therapeutics Inc||Buy||16,667||6.00||100,002|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mendlein John (CEO and Director of Atyr Pharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.